Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2025 Earnings Call Transcript
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2025 Earnings Call Transcript March 24, 2026Fennec Pharmaceuticals Inc. misses on earnings expectations.
Fennec Pharmaceuticals Inc. (FENC)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AIGH Investment Partners Orin Hirschman | 1,981,501 | $12,186,231 | +26% | 1.66% |
| 2. | Potomac Capital Management Paul Solit And Eric Singer | 224,400 | $1,380,060 | +136% | 1.2% |
| 3. | Renaissance Technologies Jim Simons | 0 | $0 | 0% | |
| 4. | Stonepine Capital Timothy P. Lynch | 0 | $0 | 0% | |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.99 | 13,965 | $97,615.35 | 15,000 | 2025-05-19 | Filing | |
| $6.75 | 1,035 | $6,986.25 | 1,035 | 2025-05-16 | Filing | |
| $0.00 | 12,500 | $0.00 | 104,271 | 2024-04-01 | Filing | |
| $0.00 | 29,167 | $0.00 | 316,638 | 2024-04-01 | Filing | |
| $6.25 | 80,000 | $500,000.00 | 4,077,214 | 2020-05-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.04 | 8,346 | $58,755.84 | 63,077 | 2026-05-11 | Filing | |
| $6.47 | 10,781 | $69,753.07 | 121,451 | 2026-05-01 | Filing | |
| $6.31 | 10,946 | $69,069.26 | 113,856 | 2026-04-01 | Filing | |
| $8.36 | 10,079 | $84,260.44 | 103,996 | 2026-03-02 | Filing | |
| $7.76 | 10,349 | $80,308.24 | 98,477 | 2026-02-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,908,201 | $17,885,436 | 7.19% | |
| 2. | 1,368,176 | $8,414,284 | 0% | |
| 3. | 897,144 | $5,517,436 | 0% | |
| 4. | 168,473 | $1,036,109 | 0% | |
| 5. | 152,123 | $935,556 | 0% |
News See All
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to Fennec Pharmaceuticals' Second Quarter 2025 Earnings and Corporate Update Conference Call.
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q1 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. And welcome to Fennec Pharmaceuticals First Quarter 2025 Earnings and Corporate Update Conference Call.
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2024 Earnings Call Transcript
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2024 Earnings Call Transcript March 10, 2025Fennec Pharmaceuticals Inc. misses on earnings expectations.
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to Fennec Pharmaceuticals Third Quarter 2024 Earnings and Corporate Update Conference Call.
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2024 Earnings Call Transcript
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2024 Earnings Call Transcript August 13, 2024Fennec Pharmaceuticals Inc. misses on earnings expectations.
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q1 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. And welcome to the Fennec Pharmaceuticals' First Quarter 2024 Earnings and Corporate Update Conference Call.
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. And welcome to the Fennec Pharmaceuticals' Fourth Quarter and Full Year 2023 Earnings and Corporate Update Conference Call.
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to Fennec Pharmaceuticals Third Quarter 2023 Earnings and Corporate Update Conference Call.
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2023 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen and welcome to the Fennec Pharmaceuticals Second Quarter 2023 Earnings and Corporate Update Conference Call.